文献速递肾移植

糖尿病捐献肾移植较等待名单的生存获益

Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-25

该观察性队列研究基于器官获取与移植网络数据库的437619例肾移植候选者,纳入8101例接受糖尿病捐献肾者和126560例接受非糖尿病捐献肾者。采用时变Cox比例风险模型分析显示,接受糖尿病捐献肾者的死亡风险较继续等待或接受非糖尿病捐献肾者低9%(aHR 0.91,95%CI 0.84-0.98),但供肾指数>85%的糖尿病捐献肾未见获益。

要点

  • 接受糖尿病捐献肾移植较等待名单死亡风险降低9%。
  • 供肾指数>85%的糖尿病捐献肾未显示生存获益。
  • 等待时间长中心的糖尿病患者获益最大。

核心结论

  • 糖尿病捐献肾与非糖尿病捐献肾相比死亡风险更高,但对许多候选者而言较等待名单提供更大生存获益。

研究设计与样本

  • 观察性队列研究,纳入器官获取与移植网络数据库437619例肾移植候选者,其中8101例接受糖尿病捐献肾,126560例接受非糖尿病捐献肾。

主要发现

  • 移植受者中位随访8.9年,死亡率为每1000人年35例死亡。
  • 接受糖尿病捐献肾者较等待名单或接受非糖尿病捐献肾者死亡风险低9%(调整风险比0.91;95%CI 0.84-0.98)。
  • 供肾指数>85%的非糖尿病捐献肾受者死亡风险更低(调整风险比0.86;95%CI 0.81-0.91),而供肾指数>85%的糖尿病捐献肾受者无差异(调整风险比1.09;95%CI 0.97-1.22)。
  • 年龄<40岁患者接受糖尿病捐献肾移植无生存获益;等待时间长中心的糖尿病患者获得最大生存获益。

临床怎么用

  • 对等待时间长、死亡风险高的糖尿病候选者,可考虑接受糖尿病捐献肾以改善生存。
  • 供肾指数>85%的糖尿病捐献肾应谨慎评估,因未显示生存获益。
  • 年轻(<40岁)患者接受糖尿病捐献肾可能无生存优势,需个体化决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Use of diabetic donor kidneys has been a necessary response to the donor organ shortage. Recipients of diabetic donor kidneys have higher mortality risk compared with recipients of nondiabetic donor kidneys. However, the survival benefit of transplantation with diabetic donor kidneys over remaining on the waitlist has not been previously evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed an observational cohort study of 437,619 kidney transplant candidates from the Organ Procurement and Transplantation Network database, including 8101 recipients of diabetic donor kidneys and 126,560 recipients of nondiabetic donor kidneys. We used time-varying Cox proportional hazards modeling to assess the mortality risk of accepting a diabetic donor kidney compared with remaining on the waitlist or receiving a nondiabetic donor kidney. RESULTS: Among transplant recipients, median follow-up was 8.9 years and mortality rate was 35 deaths per 1000 person-years. Recipients of diabetic donor kidneys had 9% lower mortality compared with remaining on the waitlist or transplantation with a nondiabetic donor kidney (adjusted hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.98). Although recipients of nondiabetic donor kidneys with a Kidney Donor Profile Index score >85% had lower mortality risk (adjusted hazard ratio, 0.86; 95% confidence interval, 0.81 to 0.91), recipients of diabetic donor kidneys with an index score >85% did not show any difference (adjusted hazard ratio, 1.09; 95% confidence interval, 0.97 to 1.22). Patients aged <40 years attained no survival benefit from transplantation with diabetic donor kidneys; diabetic patients at centers with long waitlist times attained the greatest survival benefit. CONCLUSIONS: Diabetic donor kidneys appear associated with higher mortality risk compared with nondiabetic donor kidneys, but offer greater survival benefit compared with remaining on the waitlist for many candidates. Patients with high risk of mortality on the waitlist at centers with long wait times appear to benefit most from transplantation with diabetic donor kidneys.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Cohen JB, Eddinger KC, Locke JE, et al. Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist. Clin J Am Soc Nephrol. 2017. PMID: 28546439. doi:10.2215/CJN.10280916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。